Author's response to reviews

Similar documents
(2) 83.3% b/w TST and T-SPOT, (2) 77.4% b/w TST and T-SPOT. 77.7% b/w TST and QFT-GIT. QFT-GIT, 22.2% in T-SPOT. TSPOT vs. TST (> 5 mm) vs.

Interpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm

Building Bone Density-Research Issues

The Bone Wellness Centre - Specialists in Dexa Total Body 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1

PhenX Measure: Body Composition (#020300) PhenX Protocol: Body Composition - Body Composition by Dual-Energy X-Ray Absorptiometry (#020302)

2013 ISCD Official Positions Adult

Prior treatment with non-biologic Disease- Modifying Antirheumatic. Not to be used in combination with another biologic DMARD

Prevalence of Osteoporosis p. 262 Consequences of Osteoporosis p. 263 Risk Factors for Osteoporosis p. 264 Attainment of Peak Bone Density p.

Association between bone mineral density and hearing loss in Osteogenesis Imperfecta

ADOLESCENT OBESITY: IS IT BAD FOR THE BONES

Corporate Medical Policy

The Bone Wellness Centre - Specialists in Dexa Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1

Supplementary Online Content

denosumab (Prolia ) Policy # Original Effective Date: 07/21/2011 Current Effective Date: 04/19/2017

Based on review of available data, the Company may consider the use of denosumab (Prolia) for the

Adina Alazraki, MD, FAAP Assistant Professor, Radiology and Pediatrics Emory University School of Medicine Children s Healthcare of Atlanta

Whole Body Dual X-Ray Absorptiometry to Determine Body Composition

DXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi

Author's response to reviews

DXA Body Composition Scan + Visceral Fat Analysis

Author's response to reviews

Medical Policy. MP Whole Body Dual X-Ray Absorptiometry to Determine Body Composition

Remicade. Remicade (infliximab), Inflectra (infliximab-dyyb) Description

NICE DECISION SUPPORT UNIT

DEXSIT: A Benchmark Database for BMD Measurement and Analysis #1 S.M.Nazia Fathima, *2 R.Tamilselvi, and *3 M.Parisa Beham

Clinical Study Comparison of QCT and DXA: Osteoporosis Detection Rates in Postmenopausal Women

The Bone Wellness Centre - Specialists in DEXA Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1

pqct Measurement of Bone Parameters in Young Children

CONTRACTING ORGANIZATION: Spaulding Rehabilitation Hospital, Boston, MA 02129

Index. B BMC. See Bone mineral content BMD. See Bone mineral density Bone anabolic impact, Bone mass acquisition

Title:Prevalence of binge drinking and associated behaviours among 3286 college students in France

Horizon Scanning Technology Summary. Abatacept (Orencia) for juvenile idiopathic arthritis. National Horizon Scanning Centre.

Prodigy. from GE Healthcare. Most trusted, reliable and best-selling DXA system with one of the largest installed base in the world. gehealthcare.

Whole Body Dual X-Ray Absorptiometry (DXA) to Determine Body Composition

The Bone Wellness Centre - Specialists in DEXA Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1

The Bone Wellness Centre - Specialists in DEXA Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1

Norland Densitometry A Tradition of Excellence

New Dual-energy X-ray Absorptiometry Machines (idxa) and Vertebral Fracture Assessment

ADALIMUMAB Generic Brand HICL GCN Exception/Other ADALIMUMAB HUMIRA GUIDELINES FOR USE INITIAL CRITERIA (NOTE: FOR RENEWAL CRITERIA SEE BELOW)

Corporate Medical Policy

Rahel Meinen, Inna Galli-Lysak, Peter M. Villiger and Daniel Aeberli *

MP Whole Body Dual X-Ray Absorptiometry to Determine Body Composition

Product: Denosumab (AMG 162) Clinical Study Report: month Primary Analysis Date: 21 November 2016 Page 1

1 P a g e. Systemic Juvenile Idiopathic Arthritis (SJIA) (1.3) Patients 2 years of age and older with active systemic juvenile idiopathic arthritis.

Fat Mass. Baseline. (lbs) (lbs) Composition Trend: Total. Aug 17. Apr 17. May 17. Jun 17. Jul 17. Measured Date

L.W. Sun 1,2, G. Beller 1, D. Felsenberg 1. Introduction. Original Article. Abstract

Client Sex Facility Birth Date Height Weight Measured ####, #### #### (not specified) #### #### #### ####

The Hospital for Sick Children Technology Assessment at SickKids (TASK)

Zeenat Ali, PGY3 Joseph Grisanti, MD June 7 th, 2012

Healthy aging. It s vital.

ustekinumab (Stelara )

Title: Socioeconomic conditions and number of pain sites in women

Stefano Stagi 1*, Loredana Cavalli 2, Tiziana Cavalli 3, Maurizio de Martino 1 and Maria Luisa Brandi 2

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES HUMIRA PEDIATRIC

Horizon Scanning Technology Summary. Adalimumab (Humira) for juvenile idiopathic arthritis. National Horizon Scanning Centre.

Bone Densitometry Radiation dose: what you need to know

EXAMINATION CONTENT SPECIFICATIONS ARRT BOARD APPROVED: JANUARY 2017 IMPLEMENTATION DATE: JULY 1, 2017

A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY. Julie Marie Cousins

STRUCTURED EDUCATION REQUIREMENTS IMPLEMENTATION DATE: JULY 1, 2017

Remicade. Remicade (infliximab), Inflectra (infliximab-dyyb) Description

Name of Policy: Therapeutic Apheresis, with Extracorporeal Column Immunoadsorption and Plasma Reinfusion

Coordinator of Post Professional Programs Texas Woman's University 1

TITLE: FES-Rowing versus Zoledronic Acid to Improve Bone Health in SCI

Lunar Prodigy Advance

Title: Risser Patient Satisfaction Scale: A Validation study in Greek Cancer Patients

The bone mass concept: problems in short stature

1

INFLIXIMAB Remicade (infliximab), Inflectra (infliximab-dyyb), Renflexis (infliximab-abda)

9/26/2016. The Impact of Dietary Protein on the Musculoskeletal System. Research in dietary protein, musculoskeletal health and calcium economy

2017 Blue Cross and Blue Shield of Louisiana

Title: Use of food labels by adolescents to make healthier choices on snacks: a cross sectional study from Sri Lanka

Case Finding and Risk Assessment for Osteoporosis

Title: Childhood osteomyelitis-incidence and differentiation from other acute onset musculoskeletal features in a population-based study

Name of Policy: Zoledronic Acid (Reclast ) Injection

2013 ISCD Combined Official Positions

CT Imaging of skeleton in small animals. Massimo Marenzana

Bone Densitometry. Total 30 Maximum CE 14. DXA Scanning (10) 7

Osteoporosis challenges

H.P. ACTHAR GEL (repository corticotropin injection)

ACTEMRA (tocilizumab)

Principal Investigator. General Information. Conflict of Interest. Certification Published on The YODA Project (

Title: Protocol-based management of older adults with hip fractures in Delhi, India: a feasibility study

Index. Rheum Dis Clin N Am 32 (2006) Note: Page numbers of article titles are in boldface type.

Corporate Medical Policy

Title:Factors affecting attendance to cervical cancer screening among women in the Paracentral Region of El Salvador

The Bone Wellness Centre - Specialists in DEXA Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1

Name of Policy: Boniva (Ibandronate Sodium) Infusion

Bone Mineral Densitometry with Dual Energy X-Ray Absorptiometry

Gender differences in effectiveness of treatment in rheumatic diseases

Corporate Medical Policy

AMERICAN COLLEGE OF RHEUMATOLOGY POSITION STATEMENT. Committee on Rheumatologic Care

National Institute for Health and Clinical Excellence Level 1A, City Tower Piccadilly Plaza Manchester M1 4BD

Opinion 23 July 2014

Osteoporosis: fragility fracture risk. Costing report. Implementing NICE guidance

To help you with terms and abbreviations used in this document that may be unfamiliar to you, a glossary is provided on the last pages.

Standard Operating Procedure TCRC Dual-Energy X-ray Absorptiometry (DXA)

Objectives: What is Osteoporosis 10/8/2015. Bone Health/ Osteoporosis: BASICS OF SCREENING, INTERPRETING, AND TREATING

Regulatory Status FDA- approved indication: Simponi and Simponi ARIA are tumor necrosis factor (TNF) blockers indicated for the treatment of:

Transcription:

Author's response to reviews Title:The association between lean mass and bone mineral content in the high disease activity group of adult patients with juvenile idiopathic arthritis Authors: Kristyna Brabnikova Maresova (maresova.kristyna@seznam.cz) Katerina Jarosova (jarosovak@revma.cz) Karel Pavelka (pavelka@revma.cz) Jan J Stepan (stepan@revma.cz) Version:2Date:16 January 2014 Author's response to reviews: see over

Author's response to reviews Title: The association between lean mass and bone mineral content in the high disease activity group of adult patients with juvenile idiopathic arthritis Authors: Kristyna Brabnikova Maresova (maresova.kristyna@seznam.cz) Katerina Jarosova (jarosovak@revma.cz) Karel Pavelka (pavelka@revma.cz) Jan J Stepan (stepan@revma.cz) Version: 2 Date: 16 January 2014 Author's response to reviews: see over

Reviewer #1: 1. Were the control patients supplemented with vitamin D and calcium? How long were the JIA subjects treated with vitamin D and calcium? What was the dose? The control subjects were not supplemented with vitamin D and calcium. The JIA patients were supplemented with 1000mg calcium and 800 IU vitamin D daily, for at least six months prior to evaluation. This information was added to Subjects and methods (Study design, participants). Data were added to Results and Table 1. Page 5 The control subjects were not supplemented with vitamin D and calcium. The JIA patients were supplemented with 1000 mg calcium and 800 IU vitamin D daily, for at least six months prior to evaluation. Page 8 No statistical differences of demographic characteristics between the patient and control group were found except for higher serum 25-hydroxyvitamin D levels in the JIA patients. 2. Was the selection of the control group a random selection of those who volunteered? The volunteers (100 subjects) were selected randomly from classmates, friends and acquaintances of JIA patients. The 84 controls were chosen from the volunteer group so that the age of the volunteers as much coincided with patient age. This was added to Subjects and methods (Study design, participants). Page 5 The control sample of young men and women with no fracture was recruited by invitation in the same district of Prague. The volunteer group (100 subjects) was selected randomly from classmates, friends and acquaintances of JIA patients. From these invitations, three eligible age- and gender- matched control participants (only 2 control participants in 9 females) were selected for each JIA case. 3. There is some need for editing. For instance in the abstract: delete an in the background sentence adult patients with an active juvenile idiopathic arthritis (JIA) untreated with tumor necrosis factor alpha inhibitors measures should be measured in the sentence In patients with clinically active JIA (disease activity score 28, 6.36 ± 0.64, C reactive protein, 18.36 ± 16.95 mg/l), abmd was reduced in all measures sites Quality of written English: Needs some language corrections before being published. We rephrased the relevant paragraphs and the manuscript was extensively edited professionally by the translator.

Reviewer #2: 1. The authors should tell more information about the relationship between muscles and BMC (Schoneau et al. 2002) and about weight and BMC, BMD. These informations were added to Background. Page 4. Decrease in bone mass in JIA is also associated with muscle atrophy. A linear relationship was described between muscle cross-sectional area and bone mineral content (BMC) of radial diaphysis in healthy children and adolescents [11]. The bone-muscle unit plays an important role especially in the growing bones of children and adolescents. It is the muscle forces, not body weight, that load the load-bearing bones. Bones adapt their strength to maintain the strain caused by physiological loads close to a set point and the largest physiological loads are caused by muscle contractions [12], and muscle strength thus strongly influences postnatal bone strength [13]. In JIA, inflammation, low physical activity as well as the GC therapy may be responsible for muscular atrophy. 2. Is fat mass or lean mass affected by GC use as only five patients were actually never-users of GCs. Are there differences between men and women. Are these notions to be considered in interpreting the results? We thank the reviewer for this comment. Results were calculated according to the reviewer s suggestions. Tables 3, 4 and 5 and Figure 1 are added. Page 8 and 9 (Results) In the total body as well as in the trunk and extremities (both legs and arms), no significant differences in tissue mass were observed between JIA patients and control subjects. However, in all measured regions, lean mass and BMC fraction was significantly lower, and fat mass fraction was significantly higher in JIA patients compared to controls. Significant differences in body composition between JIA and controls were also evident in both genders (Table 3). BMC was reduced in all the measured sites, lean mass was reduced as well and fat mass was increased in all measured areas except for the trunk. In women with JIA, body composition at the total body and legs was significantly different from that in women untreated with glucocorticoids and from that in women in the control group (Fig. 1). In JIA patients, significant correlations were observed between indices of composition of legs, and physical performance and disease duration (Table 4). Significant correlations were also observed in these patients between the indices of body composition by gender (Table 5). Thanks to the inclusion of a number of female patients treated with GCs, it was possible to observe a significant negative correlation

between GCs usage and BMC of legs, and between GCs usage and DAS 28. The association between lean mass and BMC in legs of women with JIA treated with GCs, not treated with GCs, and in healthy women as well as in men with JIA and control subjects is given in Figure 2. Using multiple linear regression analysis, the fraction of BMC was significantly predicted by total body lean mass both in women (total body, p = 0.002) and in men (total body, p = 0.022, and in legs, p = 0.008), while current GC therapy, DAS28, and duration of disease did not contribute significantly to the prediction of the BMC in the patients with JIA. Page 10 (Discussion) The differences between body composition of total body and legs in the subgroup of women with JIA treated and not treated with GCs indicate a negative effect of GCs on the lean mass and BMC, and the positive effect on fat tissue. This is in good agreement with several cross-sectional and longitudinal studies demonstrating substantial effects of GCs on muscle atrophy and body composition in patients with medical illnesses such as Crohn s disease, multiple sclerosis, systemic lupus erythematosus, glucocorticoid-sensitive nephrotic syndrome and post-renal transplantation [18-23]. The significant positive correlation between the activity of the disease and GC use could be explained by the necessity of GC therapy in patients with severe course of disease. However, while 9 out of 19 women patients were on GC therapy, the BMC fraction was significantly predicted by GC use rather than by DAS28. The importance of lean mass is further supported by the significant correlation between disease duration and increase of fat mass and reduction of bone and lean mass and deteriorated physical performance of legs evaluated using the chair test. In a study where lean mass and cortical and trabecular bone forearm BMD were measured using peripheral quantitative computed tomography, JIA patients had significantly reduced muscle cross-sectional area and this reduction significantly correlated with muscle strength and bone geometry abnormalities and, particularly, with reduced thickness of the cortical bone [24]. Similar conclusions were derived from the measurement of muscle and bone mass of the tibia [25]. 3. In JIA there is no general agreement about remission. Disease activity should be discussed more thoroughly and use of DAS 28 in patients with JIA. DAS 28 in JIA patients was used because the patients were adult and before TNFα blockers treatment, therefore we had to use the criteria of the Czech Rheumatology Society for therapy with TNFα inhibitors. As a crtiterion of disease aktivity, we had to use DAS 28. The improved description has been added to the text. Page 5 According to the criteria of the Czech Rheumatology Society, the basic indication for therapy with TNFα inhibitors is an unsatisfactory response to therapy with one disease-modifying anti-rheumatic drug (DMARD) (preferably methotrexate, alternatively sulphasalazine or leflunomide). DMARD therapy before TNFα blockers initiation must be at least 3-6 months with adequate dosage (methotrexate dose 20-

30mg). The other basic condition is a disease activity score 28 (DAS 28) of at least 3.9 [14]. 4. Is the precision of Lunar Prodigy reliable enough to compare fat mass and lean mass between the groups? As required by the opponent we expressed body composition (BMC, lean and fat mass) in %. Thus, we added paragraph into the section of Subjects and Methods and subsection Bone densitometry: Page 6 The availability of DXA enables the precise measurement of body composition in terms of lean and fat mass and bone mineral content of the total body, trunk, legs and arms. In our study we calculated % for lean mass, fat mass and BMC evaluation. BMC, lean mass and fat mass were measured using whole-body absorptiometry software of the bone densitometer (Prodigy, GE, U.S.A.) and were expressed in grams. Percentages of BMC, lean mass and fat mass were calculated by dividing each absolute value by total mass. For instance percentage trunk fat was calculated by dividing trunk fat mass by total fat mass and was designated (%) trunk fat. A strong correlation between body weight and total body mass as measured by DXA (r=0.98) was obtained in a preliminary study. The coefficients of variation of measurements of BMC, lean and fat mass were 0.9, 1.0 and 2.0%, respectively. 5. Quality of written English: Not suitable for publication unless extensively edited. The manuscript was extensively edited by the translator.